[Low grade fibromixoid sarcoma: a purpose of 3 cases and review of the bibliography].

antigenretrieve
April 28, 2021 0 Comments

[Low grade fibromixoid sarcoma: a purpose of 3 cases and review of the bibliography].

BACKGROUND
Low grade fibromyxoid sarcoma or tumor Evans is a variety of soft tissue sarcoma that represents 1% of all malignancies. More common in limbs and trunk (50%), we present 3 new cases of retroperitoneal reviewing their characteristics and performing a literature review.
METHODS
In the retroperitoneal location highlights the poor specificity of clinical symptoms, demonstrating, according to their growth and size, as an abdominal tumor, usually painless, or by compression and/or invasion of nearby structures. In cases that present the most important finding was the presence of a palpable abdominal tumor without other symptoms despite remarkable infiltration of other organs that should be included in surgical resection.
CONCLUSIONS
We emphasize the difficulty of correct diagnosis preoperatively because preoperative studies are inconclusive and only the histological and immunohisto-typing chemistry allow precise identification.
antigenretrieve
antigenretrieve

[Determination of ER-D5 (estrogen receptor related antigen) in prostatic cancer and its significance].

The existence of an estrogen receptor and various other sex steroid receptors has been confirmed in prostatic cancer. However, the action mechanism of hormone therapy and relationship between the disappearance of hormone response, which is observed in the recurrence of prostatic cancer, and various sex steroid receptors have yet to be identified. The use of monoclonal antibody ERICA is known as a method of detecting the estrogen receptor in the immunohistological chemistry method. However, this monoclonal antibody is difficult to use on paraffin sections. Therefore, using monoclonal antibody D5, which allows ER-D5 detection of the estrogen receptor related antigen on paraffin sections, we investigated whether or not estrogen receptors are present in the prostatic cancer preparation and studied the survival rate of prostatic cancer as well as relationship with recurrence.
Positive ER-D5 results were obtained in 37 of 93 prostatic cancer cases (39.8%) and in all 20 prostatic hypertrophy cases (100%). ER-D5 tended to be more densely stained in prostatic hypertrophy than in prostatic cancer. The survival rate was obviously higher in the ER-D5 positive prostatic cancer cases than in ER-D5 negative cases for a certain period of time after the start of treatment. Despite differences in the histo-differentiation degree and clinical stage of prostatic cancer, the ER-D5 positive percentage did not change and remained between 35% and 45%. In cases where another prostatic cancer preparation was taken because of recurrence of prostatic cancer, there were no ER-D5 positive cases at the time of recurrence.(ABSTRACT TRUNCATED AT 250 WORDS)

Activation of TRPV4 channels leads to a consistent tocolytic effect on human myometrial tissues

Background: Human myometrium is a therapeutic target for labor induction and preterm labor.
Objective: This study aimed to assess the physiological role of alternative calcium conductance on contractions triggered by uterotonic drugs in human myometrium. Membrane conductances, supported by TRPV channels, may provide alternative pathways to control either free intracellular and/or submembrane Ca2+-concentration, which in turn will modulate membrane polarization and contractile responses.
Study design: Uterine biopsies were obtained from consenting women undergoing elective caesarean delivery at term without labor (N = 22). Isometric tension measurements were performed on uterine smooth muscle strips (n = 132). Amplitude, frequency, and area under the curve (AUC) of phasic contractions, as well as resting tone, were measured under various experimental conditions. Immuno histo– and cyto-chemistry, as well as Western blot analyses, have been performed with specific antibodies against TRPV1, TRPV3, and TRPV4 proteins. TRPV4 agonists; GSK1016790A, 4αPDD, and 5,6-EET were used to assess the role of TRPV4 channels on rhythmic activity triggered by 30-300 nM oxytocin. 5 μM of ruthenium red was used as an efficient blocker of ionic current through TRPV4 channels. Nanomolar concentrations of iberiotoxin (IbTX) were also used to confirm the downstream involvement of BKCa channels in controlling uterine reactivity and contractility.
Results: The expression of TRPV3 and TRPV4 isoforms has now been demonstrated in human myometrial tissue and cell culture. Nanomolar concentrations of the TRPV4 agonists, (either GSK1016790A or 4αPDD) abolished the rhythmic contractions, resulting in a rapid and consistent tocolytic effect. While 5 μM of ruthenium reversed this tocolytic effect. The addition of IbTX (a BKCa channel blocker) reversed the effects of GSK1016790A. Carvacrol, a TRPV3 agonist, had similar tocolytic effects on rhythmic contractions albeit at higher concentrations. This inhibitory effect was also reversed by ruthenium red.
Conclusion: Collectively, these data suggest that activation of TRPV4 leads to a Ca2+ entry and subsequent BKCa channel activation (increase in open state probability), which in turn hyperpolarizes the myometrial cell membrane, inactivating L-type Ca2+ channels and efficiently abrogates contractile activity. Consequently, alternative Ca2+ conductance supported by TRPV4 plays a physiological role in the modulation of myometrial reactivity.

The real-time polymerase chain reaction.

The scientific, medical, and diagnostic communities have been presented the most powerful tool for quantitative nucleic acids analysis: real-time PCR [Bustin, S.A., 2004. A-Z of Quantitative PCR. IUL Press, San Diego, CA]. This new technique is a refinement of the original Polymerase Chain Reaction (PCR) developed by Kary Mullis and coworkers in the mid 80:ies [Saiki, R.K., et al., 1985. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia, Science 230, 1350], for which Kary Mullis was awarded the 1993 year’s Nobel prize in Chemistry.

Genorise® recombinant Bovine GM-CSF protein

GR120027 5 µg
EUR 285

Bovine GM-CSF Antibody

GWB-592EC9 0.5 mg Ask for price

GM CSF Recombinant Protein

96-356 0.02 mg
EUR 500.1
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is also known as Colony stimulating factor 2 (granulocyte-macrophage), is a cytokine initially characterized by its ability to induce colonies of granulocytes and macrophages from myeloid progenitor cells, and is secreted by macrophages, T cells, mast cells, endothelial cells and fibroblasts. GM-CSF is a cytokine that functions as a white blood cell growth factor. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exitthe circulation and migrate into tissue, whereupon they mature into macrophages and dendritic cells. Thus, it is part of the immune/inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their numbers, a process crucial for fighting infection. The active form of the protein is found extracellularly as a homodimer. Human GM-CSF glycosylated in its mature form. As a part of the immune/inflammatory cascade, GM-CSF promotes Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity, and thus worthy of consideration for therapeutic target. GM-CSF has also recently been evaluated in clinical trials for its potential as a vaccine adjuvant in HIV-infected patients. The preliminary results have been promising. GM-CSF is also used as a medication to stimulate the production of white blood cells following chemotherapy.

Recombinant Human CSF-2/GM-CSF Protein

RP02372 100μg
EUR 244.43

Bovine GM-CSF ELISA Kit

EBG0023 96Tests
EUR 625.2

Bovine GM-CSF ELISA Kit

EBG0342 96Tests
EUR 625.2

Bovine GM-CSF ELISA Kit

ELA-E0045b 96tests
EUR 796

Mouse Anti Bovine GM-CSF

MBS225634-01mg 0.1mg
EUR 425

Mouse Anti Bovine GM-CSF

MBS225634-5x01mg 5x0.1mg
EUR 1745

RABBIT ANTI BOVINE GM-CSF

MBS225882-01mg 0.1mg
EUR 645

RABBIT ANTI BOVINE GM-CSF

MBS225882-5x01mg 5x0.1mg
EUR 2730

Recombinant Mouse GM-CSF/CSF2

AP76135 1mg
EUR 3489

Recombinant Mouse GM-CSF/CSF2

CK02-10ug 10ug
EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4.

Recombinant Mouse GM-CSF/CSF2

CK02-1mg 1mg
EUR 2983.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4.

Recombinant Mouse GM-CSF/CSF2

CK02-500ug 500ug
EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4.

Recombinant Mouse GM-CSF/CSF2

CK02-50ug 50ug
EUR 595.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4.

Recombinant Human GM-CSF (CSF2)

Z100275 20 µg
EUR 85
Description: GM-CSF is a hematopoietic growth factor that is produced by endothelial cells, monocytes, fibroblasts and T-lymphocytes following their activation by antigens or mitogens. GM-CSF stimulates the development of macrophages and neutrophils and plays a role in the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. Approximately 90% of the secreted colony stimulating activities are due to GM-CSF. While non-glycosylated and glycosylated GM-CSF show similar activities in vitro, fully glycosylated GM-CSF is biologically more active in vivo compared to its non-glycosylated counterpart. Human and murine GM-CSF are species-specific and therefore, exhibit no cross-reactivity. Recombinant Human GM-CSF is a non-glycosylated, monomeric protein that contains intra-chain disulfide bonds.

Recombinant Human GM-CSF (CSF2)

Z100277 100 µg
EUR 210
Description: GM-CSF is a hematopoietic growth factor that is produced by endothelial cells, monocytes, fibroblasts and T-lymphocytes following their activation by antigens or mitogens. GM-CSF stimulates the development of macrophages and neutrophils and plays a role in the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. Approximately 90% of the secreted colony stimulating activities are due to GM-CSF. While non-glycosylated and glycosylated GM-CSF show similar activities in vitro, fully glycosylated GM-CSF is biologically more active in vivo compared to its non-glycosylated counterpart. Human and murine GM-CSF are species-specific and therefore, exhibit no cross-reactivity. Recombinant Human GM-CSF is a non-glycosylated, monomeric protein that contains intra-chain disulfide bonds.

Recombinant Human GM-CSF (CSF2)

Z100279 10 x 100 µg (Z100277 x 10)
EUR 1980
Description: GM-CSF is a monomeric protein of 127 amino acids with two glycosylation sites. The protein is synthesized as a precursor of 144 amino acids, which included a hydrophobic secretory signal sequence at the amino terminal end. The sugar moiety is not required for the full spectrum of biological activities. Non-glycosylated and glycosylated GM-CSF show the same activities in vitro. Fully glycosylated GM-CSF is biologically more active in vivo than the non-glycosylated protein. This protein is secreted together with other factors by T cells and macrophages following cell activation by antigens or mitogens. Approximately 90% of the secreted colony stimulating activities are due to GM-CSF.

Recombinant Mouse GM-CSF (CSF2)

Z200075 20 µg
EUR 190
Description: GM-CSF is a monomeric cytokine with two glycosylation sites that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes. CSF2 is secreted together with other factors by T cells and macrophages following cell activation by antigens or mitogens. The signalling ‘GM-CSF:receptor’ complex is a dodecamer of two hexamers of two alpha, two beta, and two ligand subunits. While non-glycosylated and glycosylated GM-CSF show similar activities in vitro, fully glycosylated GM-CSF is biologically more active in vivo. Recombinant Mouse CSF2 is a non-glycosylated, monomeric protein.

Recombinant Mouse GM-CSF (CSF2)

Z200077 5 x 20 µg (Z200075 x 5)
EUR 850
Description: GM-CSF is a monomeric cytokine with two glycosylation sites that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes. CSF2 is secreted together with other factors by T cells and macrophages following cell activation by antigens or mitogens. The signalling ‘GM-CSF:receptor’ complex is a dodecamer of two hexamers of two alpha, two beta, and two ligand subunits. While non-glycosylated and glycosylated GM-CSF show similar activities in vitro, fully glycosylated GM-CSF is biologically more active in vivo. Recombinant Mouse CSF2 is a non-glycosylated, monomeric protein.

Recombinant Mouse GM-CSF (CSF2)

Z200079 1.0 mg
EUR 4350
Description: GM-CSF is a monomeric protein of 127 amino acids with two glycosylation sites. The protein is synthesized as a precursor of 144 amino acids, which included a hydrophobic secretory signal sequence at the aminoterminal end. The sugar moiety is not required for the full spectrum of biological activities. Non-glycosylated and glycosylated GM-CSF show the same activities in vitro. Fully glycosylated GM-CSF is biologically more active in vivo than the non- glycosylated protein. This protein is secreted together with other factors by T cells and macrophages following cell activation by antigens or mitogens. Approximately 90% of the secreted colony stimulating activities are due to GM-CSF.

Recombinant Human GM-CSF (CSF2)

MBS4159657-002mg 0.02mg
EUR 230

Recombinant Human GM-CSF (CSF2)

MBS4159657-01mg 0.1mg
EUR 360

Recombinant Human GM-CSF (CSF2)

MBS4159657-10x01mg 10x0.1mg
EUR 2405

Recombinant Mouse GM-CSF (CSF2)

MBS4159924-002mg 0.02mg
EUR 340

Recombinant Mouse GM-CSF (CSF2)

MBS4159924-1mg 1mg
EUR 5115

Recombinant Mouse GM-CSF (CSF2)

MBS4159924-5x002mg 5x0.02mg
EUR 1100

Recombinant Mouse GM-CSF (CSF2)

MBS4159924-5x1mg 5x1mg
EUR 22780

Recombinant Human GM-CSF/CSF2

PH2025-.01 10ug
EUR 208
Description: Peptides & Proteins|Recombinant Proteins

Recombinant Human GM-CSF/CSF2

PH2025-.1 10X10ug
EUR 755.2
Description: Peptides & Proteins|Recombinant Proteins

Granulocyte Macrophage Colony Stimulating Factor, Recombinant, Bovine (GM-CSF, GMCSF, CSF, Colony Stimulating Factor, CSF2, Colony Stimulating Factor 2 (Granulocyte-Macrophage))

MBS650402-1mL 1mL
EUR 715

Granulocyte Macrophage Colony Stimulating Factor, Recombinant, Bovine (GM-CSF, GMCSF, CSF, Colony Stimulating Factor, CSF2, Colony Stimulating Factor 2 (Granulocyte-Macrophage))

MBS650402-5x1mL 5x1mL
EUR 3075

Active Recombinant Rat CSF-2/GM-CSF Protein

RP01207 5 μg
EUR 195

Active Recombinant Human CSF-2/GM-CSF Protein

RP00094 5 μg
EUR 39

Active Recombinant Mouse CSF-2/GM-CSF Protein

RP01206 5 μg
EUR 58.5

Genorise® recombinant Bovine M-CSF protein

GR120033 5 µg
EUR 285

Genorise® recombinant Bovine G-CSF protein

GR120034 5 µg
EUR 285

Recombinant Rat GM-CSF/CSF2 Protein

MBS9144114-0005mg 0.005mg
EUR 140

Recombinant Rat GM-CSF/CSF2 Protein

MBS9144114-002mg 0.02mg
EUR 190

Recombinant Rat GM-CSF/CSF2 Protein

MBS9144114-005mg 0.05mg
EUR 260

Recombinant Rat GM-CSF/CSF2 Protein

MBS9144114-01mg 0.1mg
EUR 360

Recombinant Rat GM-CSF/CSF2 Protein

MBS9144114-5x01mg 5x0.1mg
EUR 1445

Recombinant Rat GM-CSF/CSF2 Protein

RP00576 50μg
EUR 49.6

Recombinant Mouse GM-CSF/CSF2 Protein

MBS9144113-002mg 0.02mg
EUR 190

Recombinant Mouse GM-CSF/CSF2 Protein

MBS9144113-005mg 0.05mg
EUR 260

Recombinant Mouse GM-CSF/CSF2 Protein

MBS9144113-01mg 0.1mg
EUR 360

Recombinant Mouse GM-CSF/CSF2 Protein

MBS9144113-5x01mg 5x0.1mg
EUR 1445

Recombinant Human GM-CSF/CSF2 Protein

MBS9139691-0005mg 0.005mg
EUR 140

Recombinant Human GM-CSF/CSF2 Protein

MBS9139691-002mg 0.02mg
EUR 190

Recombinant Human GM-CSF/CSF2 Protein

MBS9139691-005mg 0.05mg
EUR 235

Recombinant Human GM-CSF/CSF2 Protein

MBS9139691-01mg 0.1mg
EUR 315

Recombinant Human GM-CSF/CSF2 Protein

MBS9139691-5x01mg 5x0.1mg
EUR 1235

Recombinant Mouse GM-CSF/CSF2 Protein

MBS2553508-002mg 0.02mg
EUR 270

Recombinant Mouse GM-CSF/CSF2 Protein

MBS2553508-01mg 0.1mg
EUR 690

Recombinant Mouse GM-CSF/CSF2 Protein

MBS2553508-5x01mg 5x0.1mg
EUR 3105

Recombinant Human GM-CSF/CSF2 Protein

MBS2552278-002mg 0.02mg
EUR 295

Recombinant Human GM-CSF/CSF2 Protein

MBS2552278-5x002mg 5x0.02mg
EUR 1320

Recombinant Human GM-CSF/CSF2 Protein

MBS2552732-001mg 0.01mg
EUR 180

Recombinant Human GM-CSF/CSF2 Protein

MBS2552732-005mg 0.05mg
EUR 380

Recombinant Human GM-CSF/CSF2 Protein

MBS2552732-5x005mg 5x0.05mg
EUR 1690

Recombinant Human GM-CSF/CSF2 Protein

MBS2557271-002mg 0.02mg
EUR 270

Recombinant Human GM-CSF/CSF2 Protein

MBS2557271-01mg 0.1mg
EUR 690

Recombinant Human GM-CSF/CSF2 Protein

MBS2557271-5x01mg 5x0.1mg
EUR 3105

Recombinant Human GM-CSF/CSF2 Protein

RP00473 10μg
EUR 194.84

Recombinant Mouse GM-CSF/CSF2 Protein

RP00662 50μg
EUR 85.02

RABBIT ANTI BOVINE GM-CSF: Biotin

MBS225883-005mg 0.05mg
EUR 645

RABBIT ANTI BOVINE GM-CSF: Biotin

MBS225883-5x005mg 5x0.05mg
EUR 2730

Recombinant Human GM-CSF/CSF2 (E. coli)

AP74770 1mg
EUR 2599

Recombinant Human GM-CSF/CSF2 (E. coli)

C003-10ug 10ug
EUR 201.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Mannitol, pH 7.2.

Recombinant Human GM-CSF/CSF2 (E. coli)

C003-1mg 1mg
EUR 2203.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Mannitol, pH 7.2.

Recombinant Human GM-CSF/CSF2 (E. coli)

C003-500ug 500ug
EUR 1557.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Mannitol, pH 7.2.

Recombinant Human GM-CSF/CSF2 (E. coli)

C003-50ug 50ug
EUR 486
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Mannitol, pH 7.2.

Recombinant Mouse GM-CSF/CSF2 (C-6His)

AP76095 1mg
EUR 3489

Recombinant Mouse GM-CSF/CSF2 (C-6His)

CJ46-10ug 10ug
EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4.

Recombinant Mouse GM-CSF/CSF2 (C-6His)

CJ46-1mg 1mg
EUR 2983.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4.

Recombinant Mouse GM-CSF/CSF2 (C-6His)

CJ46-500ug 500ug
EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4.

Recombinant Mouse GM-CSF/CSF2 (C-6His)

CJ46-50ug 50ug
EUR 595.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl, pH7.4.

Recombinant Bovine CSF1 Protein

CSF1-4398B 25 µg
EUR 498.4
Description: Store at -20 centigrade.

Recombinant Human GM-CSF/CSF2 (P. pastoris)

AP74796 1mg
EUR 2929

Recombinant Human GM-CSF/CSF2 (P. pastoris)

C040-10ug 10ug
EUR 187.2
Description: Lyophilized from a 0.2 μm filtered solution of 10mM TrisHCl, 4% Mannitol, 1% Sucrose, pH 8.5.

Recombinant Human GM-CSF/CSF2 (P. pastoris)

C040-1mg 1mg
EUR 2496
Description: Lyophilized from a 0.2 μm filtered solution of 10mM TrisHCl, 4% Mannitol, 1% Sucrose, pH 8.5.

Recombinant Human GM-CSF/CSF2 (P. pastoris)

C040-500ug 500ug
EUR 1765.2
Description: Lyophilized from a 0.2 μm filtered solution of 10mM TrisHCl, 4% Mannitol, 1% Sucrose, pH 8.5.

Recombinant Human GM-CSF/CSF2 (P. pastoris)

C040-50ug 50ug
EUR 442.8
Description: Lyophilized from a 0.2 μm filtered solution of 10mM TrisHCl, 4% Mannitol, 1% Sucrose, pH 8.5.

Nori® Bovine GM-CSF ELISA Kit

GR112275 96-well
EUR 461

Recombinant Mouse GM-CSF/CSF2 Protein (Active)

PKSM041031-100ug 100ug
EUR 739
Description: Mouse

Recombinant Mouse GM-CSF/CSF2 Protein (Active)

PKSM041031-20ug 20ug
EUR 249
Description: Mouse

GM-CSF, rat recombinant

4102-10 each
EUR 307.2

GM-CSF, rat recombinant

4102-100 each
EUR 966

GM-CSF, rat recombinant

4102-1000 each
EUR 4561.2

GM-CSF, rat recombinant

P1014-.1 100 µg
EUR 809
Description: GM-CSF, pleiotropic cytokine, expressed in E.Coli, active in mouse cells.

GM-CSF, rat recombinant

P1014-1 1 mg
EUR 4017
Description: GM-CSF, pleiotropic cytokine, expressed in E.Coli, active in mouse cells.

Recombinant Rat GM-CSF

REOPP-0701 5ug Ask for price

GM-CSF, rat recombinant

P1014-.005 5ug
EUR 108.8
Description: Growth Factors|Colony Stimulating Factor

GM-CSF, rat recombinant

P1014-.5 500ug
EUR 2189.6
Description: Growth Factors|Colony Stimulating Factor

Recombinant Bovine herpesvirus 1.1 Envelope glycoprotein M (gM), partial

MBS1148314-1mgEColi 1mg(E-Coli)
EUR 2175

Recombinant Bovine herpesvirus 1.1 Envelope glycoprotein M (gM), partial

MBS1148314-1mgYeast 1mg(Yeast)
EUR 2620

Recombinant Human GM-CSF

6585 5 µg
EUR 194

GM-CSF, human recombinant

4100-10 each
EUR 307.2

GM-CSF, human recombinant

4100-100 each
EUR 874.8

GM-CSF, human recombinant

4100-1000 each
EUR 3974.4

Recombinant Human GM-CSF

HEOPP-0704 5ug Ask for price

Recombinant Human GM-CSF

EPT108 500ug
EUR 1553.4
Description: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor is produced by our Yeast expression system and the target gene encoding Ala18-Glu144 is expressed.

Recombinant Mouse GM-CSF

EPT161 50ug
EUR 491.4
Description: Recombinant Mouse Granulocyte-Macrophage Colony-Stimulating Factor is produced by our E.coli expression system and the target gene encoding Ala18-Lys141 is expressed.

Mouse GM-CSF Recombinant

IMSGMCSFR25UG each
EUR 482
Description: Mouse GM-CSF Recombinant

Mouse GM-CSF Recombinant

IMSGMCSFR5UG each
EUR 283
Description: Mouse GM-CSF Recombinant

GM-CSF, human recombinant

P1012-.01 10 µg
EUR 293
Description: GM-CSF, pleiotropic cytokine, species specific, expressed in E.Coli.

GM-CSF, human recombinant

P1012-.1 100 µg
EUR 960
Description: GM-CSF, pleiotropic cytokine, species specific, expressed in E.Coli.

GM-CSF, human recombinant

P1012-1 1 mg
EUR 4608
Description: GM-CSF, pleiotropic cytokine, species specific, expressed in E.Coli.

Recombinant Human GM-CSF

SJA01-03 10µg/vial
EUR 342

Recombinant Human GM-CSF

SJA01-04 50µg/vial
EUR 846

Recombinant Mouse GM-CSF

SJF05-01 10µg/vial
EUR 307.2

Recombinant Mouse GM-CSF

SJF05-02 50µg/vial
EUR 690

GM-CSF (human), (recombinant)

MBS567252-01mg 0.1mg
EUR 1030

GM-CSF (human), (recombinant)

MBS567252-5x01mg 5x0.1mg
EUR 4595

GM-CSF (mouse), (recombinant)

MBS567253-01mg 0.1mg
EUR 1030

GM-CSF (mouse), (recombinant)

MBS567253-5x01mg 5x0.1mg
EUR 4595

Recombinant Human GM-CSF

MBS7615914-005mg 0.05mg
EUR 560

Recombinant Human GM-CSF

MBS7615914-02mg 0.2mg
EUR 1060

Recombinant Human GM-CSF

MBS7615914-1mg 1mg
EUR 3065

Leave a Reply

Your email address will not be published. Required fields are marked *